|
|
||||||||
The Journal of Immunology, Vol 144, Issue 2 599-606, Copyright © 1990 by American Association of Immunologists
ARTICLES |
RJ Klaassen, WH Ouwehand, TW Huizinga, CP Engelfriet and AE von dem Borne
Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, University of Amsterdam, The Netherlands.
FcRIII is not present on peripheral blood monocytes, but becomes expressed upon culturing and can be demonstrated on tissue macrophages. We studied the expression of FcRIII of cultured monocytes in detail and compared its structure with FcRIII of neutrophils and NK cells. The cell density of FcRIII reached a plateau within 3 days of culturing. During that time, the expression of FcRI and FcRIIa, also present on monocytes, did not change significantly. FcRIII on cultured monocytes lacked, as did NK cell FcRIII, the NA1-allotypic variant of the NA system present on the neutrophil FcRIII. Studies with glycosyl- phosphatidyl-inositol-specific phospholipase C and analysis of cells of patients with paroxysmal nocturnal hemoglobinuria revealed that FcRIII on cultured monocytes is not anchored by phosphatidyl-inositol-glycan in the cell membrane. Similarly, FcRIII on NK cells was resistant to glycosyl-phosphatidyl-inositol-specific phospholipase C treatment, suggesting that NK cell FcRIII is also not anchored by a phosphatidyl- inositol-glycan moiety, in contrast to neutrophil FcRIII. Analysis by SDS-PAGE showed that the FcRIII of cultured monocytes had a similar mobility as the FcRIII on NK cells, but was clearly distinct from neutrophil FcRIII. Treatment with N-glycanase showed that the protein backbone of deglycosylated FcRIII of cultured monocytes was similar to that of FcRIII of NK cells, but deglycosylated neutrophil FcRIII was different. Specific blocking of FcRIII of cultured monocytes with an anti-FcRIII mAb did not reduced the lytic action of the cultured monocytes towards sensitized erythrocytes. However, FcRIII was modulated from the cell surface by incubation with sensitized E, whereas non-FcR Ag were not. These findings indicate that FcRIII is involved in binding of immune complexes, but does not act as a trigger molecule for extracellular lysis of sensitized E.
This article has been cited by other articles:
![]() |
S. Miescher, M. O. Spycher, H. Amstutz, M. de Haas, M. Kleijer, U. J. Kalus, H. Radtke, A. Hubsch, I. Andresen, R. M. Martin, et al. A single recombinant anti-RhD IgG prevents RhD immunization: association of RhD-positive red blood cell clearance rate with polymorphisms in the Fc{gamma}RIIA and Fc{gamma}IIIA genes Blood, June 1, 2004; 103(11): 4028 - 4035. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Sweeney and Y. B. Kim Identification of a Novel Fc{gamma}RIIIa{alpha}-Associated Molecule That Contains Significant Homology to Porcine Cathelin J. Immunol., January 15, 2004; 172(2): 1203 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Crowe, T. Zhu, and W. A. Muller The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection J. Leukoc. Biol., November 1, 2003; 74(5): 635 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Nockher and J. E. Scherberich Expanded CD14+ CD16+ Monocyte Subpopulation in Patients with Acute and Chronic Infections Undergoing Hemodialysis Infect. Immun., June 1, 1998; 66(6): 2782 - 2790. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagarajan, S. Chesla, L. Cobern, P. Anderson, C. Zhu, and P. Selvaraj Ligand Binding and Phagocytosis by CD16 (Fc [IMAGE] Receptor III) Isoforms J. Biol. Chem., October 27, 1995; 270(43): 25762 - 25770. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |